Tackling Early Morbidity and Mortality in myeloma: assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Acronyms TEAMM
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 04 Nov 2016 Status changed from completed to active, no longer recruiting.
- 03 Dec 2015 Accrual to date is 86% according to the United Kingdom Clinical Research Network record.